Literature DB >> 10448492

Experience with invasive Candida infections.

H Girishkumar1, A M Yousuf, J Chivate, E Geisler.   

Abstract

Between January and July 1995, 227 patients at the Bronx-Lebanon Hospital Center had positive fungal cultures. Candida spp were the most common fungi isolated. Forty-three patients with invasive disease, as indicated by fungus-positive blood cultures, became the focus of our study. C albicans caused fungaemia in 21 patients (49%). Twenty-eight patients (65%) were less than 50 years of age; three were neonates. The most common presenting symptoms were fever, chills, and weakness (20 patients, 47%). Thirty patients died, giving a mortality rate of 70%. The patients who died stayed in the hospital an average of 49 days. The highest mortality occurred among patients who became bacteraemic before or at the same time they became candidaemic (24 of 26 patients) or who were receiving broad-spectrum antibiotics (20 of 26 patients). We also found high mortality rates from invasive fungal infection among patients with HIV infection, a central venous catheter, and liver, renal, or respiratory failure. We did not find any increase in the incidence of invasive fungal infection or mortality among leukopenic or diabetic patients.

Entities:  

Mesh:

Year:  1999        PMID: 10448492      PMCID: PMC1741158          DOI: 10.1136/pgmj.75.881.151

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  14 in total

1.  Candidemia in non-neutropenic critically ill patients: analysis of prognostic factors and assessment of systemic antifungal therapy. Study Group of Fungal Infection in the ICU.

Authors:  J Nolla-Salas; A Sitges-Serra; C León-Gil; J Martínez-González; M A León-Regidor; P Ibáñez-Lucía; J M Torres-Rodríguez
Journal:  Intensive Care Med       Date:  1997-01       Impact factor: 17.440

2.  Risk factors for candidemia in cancer patients: a case-control study.

Authors:  A Karabinis; C Hill; B Leclercq; C Tancrède; D Baume; A Andremont
Journal:  J Clin Microbiol       Date:  1988-03       Impact factor: 5.948

3.  Increase in Candida krusei infection among patients with bone marrow transplantation and neutropenia treated prophylactically with fluconazole.

Authors:  J R Wingard; W G Merz; M G Rinaldi; T R Johnson; J E Karp; R Saral
Journal:  N Engl J Med       Date:  1991-10-31       Impact factor: 91.245

Review 4.  Candida infections: an overview.

Authors:  F C Odds
Journal:  Crit Rev Microbiol       Date:  1987       Impact factor: 7.624

5.  Risk factors for hospital-acquired candidemia. A matched case-control study.

Authors:  S B Wey; M Mori; M A Pfaller; R F Woolson; R P Wenzel
Journal:  Arch Intern Med       Date:  1989-10

6.  Risk factors for fungemia in children infected with human immunodeficiency virus: a case-control study.

Authors:  C E Gonzalez; D Venzon; S Lee; B U Mueller; P A Pizzo; T J Walsh
Journal:  Clin Infect Dis       Date:  1996-09       Impact factor: 9.079

7.  Secular trends in the epidemiology of nosocomial fungal infections in the United States, 1980-1990. National Nosocomial Infections Surveillance System.

Authors:  C Beck-Sagué; W R Jarvis
Journal:  J Infect Dis       Date:  1993-05       Impact factor: 5.226

Review 8.  Prevention of invasive fungal infections in patients with neoplastic disease.

Authors:  T J Walsh; J W Lee
Journal:  Clin Infect Dis       Date:  1993-11       Impact factor: 9.079

9.  Candida sepsis in surgical patients.

Authors:  P J Eubanks; C de Virgilio; S Klein; F Bongard
Journal:  Am J Surg       Date:  1993-12       Impact factor: 2.565

Review 10.  Fungal infection in surgical patients.

Authors:  D A Dean; K W Burchard
Journal:  Am J Surg       Date:  1996-03       Impact factor: 2.565

View more
  1 in total

1.  In vivo and in vitro anaerobic mating in Candida albicans.

Authors:  Raluca Dumitru; Dhammika H M L P Navarathna; Camile P Semighini; Christian G Elowsky; Razvan V Dumitru; Daniel Dignard; Malcolm Whiteway; Audrey L Atkin; Kenneth W Nickerson
Journal:  Eukaryot Cell       Date:  2007-01-26
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.